PNC Financial Services Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3K | Sell |
11,745
-81
| -0.7% | -$195 | ﹤0.01% | 3406 |
|
|
2025
Q1 | $26.1K | Buy |
11,826
+604
| +5% | +$1.34K | ﹤0.01% | 3421 |
|
|
2024
Q4 | $61.2K | Sell |
11,222
-374
| -3% | -$2.04K | ﹤0.01% | 2976 |
|
|
2024
Q3 | $96.4K | Sell |
11,596
-225
| -2% | -$1.87K | ﹤0.01% | 2692 |
|
|
2024
Q2 | $84.6K | Sell |
11,821
-1,755
| -13% | -$12.6K | ﹤0.01% | 2725 |
|
|
2024
Q1 | $118K | Buy |
13,576
+3,073
| +29% | +$26.6K | ﹤0.01% | 2517 |
|
|
2023
Q4 | $68.8K | Sell |
10,503
-139
| -1% | -$910 | ﹤0.01% | 2805 |
|
|
2023
Q3 | $106K | Buy |
10,642
+1,380
| +15% | +$13.8K | ﹤0.01% | 2532 |
|
|
2023
Q2 | $115K | Buy |
9,262
+439
| +5% | +$5.46K | ﹤0.01% | 2560 |
|
|
2023
Q1 | $124K | Buy |
8,823
+1,621
| +23% | +$22.7K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $103K | Buy |
7,202
+7,141
| +11,707% | +$102K | ﹤0.01% | 2545 |
|
|
2022
Q3 | $1K | Sell |
61
-11
| -15% | -$180 | ﹤0.01% | 4336 |
|
|
2022
Q2 | $3K | Sell |
72
-166
| -70% | -$6.92K | ﹤0.01% | 4120 |
|
|
2022
Q1 | $8K | Buy |
238
+144
| +153% | +$4.84K | ﹤0.01% | 3886 |
|
|
2021
Q4 | $4K | Sell |
94
-88
| -48% | -$3.75K | ﹤0.01% | 4026 |
|
|
2021
Q3 | $8K | Buy |
182
+55
| +43% | +$2.42K | ﹤0.01% | 3815 |
|
|
2021
Q2 | $5K | Buy |
+127
| New | +$5K | ﹤0.01% | 3885 |
|